Ventas Aktie News

Not all REITs are worth buying. In fact, some of them are facing severe difficulties. I highlight which REITs to avoid going into 2026.

Ventas, Inc. has surged 23% since July, recently hitting new 52-week highs and consolidating above its 30-week EMA. Despite overvaluation by fundamental metrics, VTR exhibits strong technical momentum, bullish volume, and institutional accumulation. Short- and long-term momentum readings are bullish, with the PPO indicator at 5.350 and volume supporting continued strength.

Ventas has evolved into a growth REIT, driven by strong SHOP portfolio execution and disciplined acquisitions below replacement cost. VTR delivered strong normalized FFO/share growth in Q3 2025, with management raising full-year FFO and NOI growth guidance on robust SHOP performance. Despite trading above historical P/FFO, VTR's premium is justified by accelerating FFO and NOI growth, demograph...

REITs remain attractively valued, with many trading at near 10-year high dividend yields. AFFO yield plus AFFO growth is utilized as a scoring system in this article. ARE leads in value but faces risks from declining occupancy and potential AFFO contraction. Others in the top 5 include VICI, IRM, EQIX and PSA.

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) today announced that its Board of Directors has declared a quarterly dividend of $0.48 per common share. The dividend will be payable in cash on January 15, 2026, to stockholders of record as of the close of business on December 31, 2025. About Ventas Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptiona...

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit's REITworld 2025 Annual Conference (the “Nareit Conference”) on December 8-9, 2025. Written materials that the Company expects to use in connection with its participation at the Nareit Conference will be made available on the Company's we...

The price-to-net asset value valuations for publicly listed US equity real estate investment trusts rose in November, after two consecutive months of decline. US equity REITs closed November at a median 18.2% discount to their consensus NAV per share estimates, according to S&P Global Market Intelligence data. Healthcare REITs posted the highest median premium to NAV.

Demand tailwinds from the aging Baby Boomer cohort and record-low new construction underpin a multi-year runway for double-digit internal and external growth. Premiums to NAV enable accretive acquisitions, and current valuations underestimate the durability and longevity of the SH cycle for these REITs. VTR, WELL, and AHR are best positioned to benefit from exceptional internal growth combined ...